SCHEMBL753129

SCHEMBL753129

COC(=O)c1ccc(COc2ccc([C@@H](C)[C@@](O)(c3ccnc(Cl)c3)C(F)(F)F)c(Cl)c2)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.43
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.34
GRM7 Q14831 1/20 0.34
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
MRGPRX4 Q96LA9 2/20 0.34
GLA P06280 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
LNPEP Q9UIQ6 1/20 0.33
PDK1 Q15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480011 1.00 HDAC8 (0.43) HDAC8ALDH1A1MAPTGAAL3MBTL1
SCHEMBL479916 0.93 HDAC8 (0.44) HDAC8ALDH1A1MAPTGAAL3MBTL1
SCHEMBL755439 0.93 HDAC8 (0.41) HDAC8ALDH1A1MAPTGAAL3MBTL1
SCHEMBL479853 0.93 HDAC8 (0.41) HDAC8ALDH1A1MAPTGAAL3MBTL1
SCHEMBL479820 0.93 HDAC8 (0.44) HDAC8ALDH1A1MAPTGAAL3MBTL1
SCHEMBL479890 0.87 TLR4 (0.33) LMNAHPGDMRGPRX4PDK1PDK2
SCHEMBL479826 0.86 HDAC8 (0.43) HDAC8ALDH1A1MAPTGAAL3MBTL1
SCHEMBL480160 0.85 PDK1 (0.43) ALDH1A1L3MBTL1HTTTSHRMRGPRX4
SCHEMBL479831 0.85 HDAC8 (0.43) HDAC8ALDH1A1MAPTGAAL3MBTL1
SCHEMBL480115 0.84 LMNA (0.40) HDAC8ALDH1A1LMNAKMT2APDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 HDAC8 1978/4885ALDH1A1 317/4885MAPT 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.